GRI Bio Inc. (GRI) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    GRI Bio Inc.

    NASDAQ: GRI · Real-Time Price · USD
    1.95
    0.02 (1.04%)
    At close: Sep 26, 2025, 3:59 PM
    1.95
    0.00%
    After-hours: Sep 26, 2025, 07:56 PM EDT

    GRI Bio Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 22.54M n/a n/a n/a
    Cost of Revenue
    		 11.63M n/a n/a n/a
    Gross Profit
    		 10.91M n/a n/a n/a
    Operating Income
    		 -8.23M -11.39M -2.24M -1.06M
    Interest Income
    		 25K n/a n/a n/a
    Pretax Income
    		 -8.21M -13.04M -3.22M -1.56M
    Net Income
    		 -8.21M -13.04M -3.22M -1.56M
    Selling & General & Admin
    		 4.47M 8.15M 2M 813K
    Research & Development
    		 3.77M 3.23M 242K 249K
    Other Expenses
    		 n/a n/a n/a n/a
    Operating Expenses
    		 8.23M 11.39M 2.24M 1.06M
    Interest Expense
    		 -6K 2.08M 653K 547K
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 8.23M 11.39M 2.24M 1.06M
    Income Tax Expense
    		 n/a n/a n/a n/a
    Shares Outstanding (Basic)
    		 183.28K 44.18K 32.49K 324.87K
    Shares Outstanding (Diluted)
    		 183.28K 44.18K 32.49K 324.87K
    EPS (Basic)
    		 -55.21 -6.24K -165.35K -815.8
    EPS (Diluted)
    		 -55.21 -6.24K -165.35K -815.8
    EBITDA
    		 -8.23M -10.9M -2.51M -963K
    EBIT
    		 -8.23M -10.96M -2.56M -1.01M
    Depreciation & Amortization
    		 4K 57K 50K 73K

    Add to Watchlist